Clinical Trial Update: Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating granulocyte colony-stimulating factor as a stem cell therapy for acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))

Snippet

Sponsor: Clinical Institute of the Brain, Russia | Conditions: Ischemic Stroke | Phase 2 | Status: COMPLETED